Adipotide vs Tirzepatide
Emerging vs FDA Approved
monitor Researched · 90% Overlapping weight-loss effects; monitor kidney function, volume status, electrolytes.
Molecular Data
Adipotide Tirzepatide
Weight N/A 4,813.55 Da
Half-life Not established ~5 days (120 hours)
Chain N/A 39 amino acids
Type Chimeric peptidomimetic Dual GLP-1/GIP agonist
Key Benefits
Adipotide
01 Rapid fat-mass reduction via selective white adipose tissue vascular targeting
02 Improved insulin sensitivity following adipose reduction
03 Non-CNS peripheral mechanism distinct from appetite suppressants
Tirzepatide
01 Dramatic weight loss (15-22% body weight)
02 Superior diabetes control
03 Reduced cardiovascular risk (26% reduction in MACE)
04 Improved insulin sensitivity
05 Appetite suppression
06 Preserved muscle mass with exercise
Dosing Protocols
Adipotide
0.43 mg/kg / Once daily
Primate Research Replication 0.43 mg/kg Once daily
Dose-Finding (Research) 0.10-0.75 mg/kg Once daily (escalating tiers)
Tirzepatide
2.5mg starting, titrate up to 5-15mg weekly / Once weekly (same day each week)
Weight loss initiation 2.5mg Once weekly x 4 weeks
Weight loss progression 5mg Once weekly
Weight loss optimization 7.5-10mg Once weekly
Maximum weight loss 12.5-15mg Once weekly
Diabetes management (mild) 5-7.5mg Once weekly
Diabetes management (severe) 10-15mg Once weekly
Side Effects
Adipotide
Mild creatinine elevation
Electrolyte shifts
Dose-dependent proximal tubule changes (reversible in primates)
Tirzepatide
Nausea (mild to moderate, first 2-4 weeks)
Appetite reduction
Possible fatigue during adaptation
Diarrhea or constipation
Reduced food cravings
Contraindications
Pregnancy/lactation (not studied)
Dehydration
Concurrent nephrotoxic medications
Personal or family history of medullary thyroid carcinoma
Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Pregnancy or breastfeeding
History of pancreatitis
Research Evidence
Adipotide Tirzepatide
Status Emerging FDA Approved
References 4 studies 8 studies
Latest — 2025-12
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.